Viewing Study NCT01624766


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2026-01-01 @ 3:15 PM
Study NCT ID: NCT01624766
Status: COMPLETED
Last Update Posted: 2021-02-25
First Post: 2012-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2011-1043
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View